相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study
Hokyou Lee et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review
Bertrand Cariou et al.
DIABETES OBESITY & METABOLISM (2021)
Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study
Yu-ling Chen et al.
BMC GASTROENTEROLOGY (2021)
Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States
Donghee Kim et al.
JOURNAL OF HEPATOLOGY (2021)
Effects of Cirrhosis and Diagnosis Scenario in Metabolic-Associated Fatty Liver Disease-Related Hepatocellular Carcinoma
Vincent L. Chen et al.
HEPATOLOGY COMMUNICATIONS (2021)
Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes
Rosa Lombardi et al.
LIVER INTERNATIONAL (2020)
Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease
Angeliki Katsarou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Comparison of MAFLD and NAFLD diagnostic criteria in real world
Su Lin et al.
LIVER INTERNATIONAL (2020)
Reply to: correspondence regarding A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement Bringing evidence to the NAFLD-MAFLD debate
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
Sakura Yamamura et al.
LIVER INTERNATIONAL (2020)
The Role of Thyroid Hormones and Autoantibodies in Metabolic Dysfunction Associated Fatty Liver Disease: TgAb May Be a Potential Protective Factor
Xiaofu Zhang et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Association of high-sensitivity C-reactive protein (hs-CRP) with non-alcoholic fatty liver disease (NAFLD) in Asian Indians: A cross-sectional study
Rahul Kumar et al.
JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE (2020)
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Peter J. Eddowes et al.
GASTROENTEROLOGY (2019)
Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications
Claudio Tana et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2019)
How the association between obesity and inflammation may lead to insulin resistance and cancer
Mohammad Nurul Amin et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis
Alessandro Mantovani et al.
DIABETES CARE (2018)
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study
Eduardo Vilar-Gomez et al.
GASTROENTEROLOGY (2018)
Liver inflammation and fibrosis
Yukinori Koyama et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
The Associations of Serum Uric Acid with Obesity-Related Acanthosis nigricans and Related Metabolic Indices
Cuiling Zhu et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2017)
Hepatic glucose and lipid metabolism
John G. Jones
DIABETOLOGIA (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis
Stefano Ballestri et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies
L. Li et al.
OBESITY REVIEWS (2016)
LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes
Pingping Li et al.
NATURE MEDICINE (2015)
Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes
Nathalie Esser et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Non-Alcoholic Fatty Liver Disease Is Closely Associated with Sub-Clinical Inflammation: A Case-Control Study on Asian Indians in North India
Priyanka Nigam et al.
PLOS ONE (2013)
Obesity and Inflammation: Epidemiology, Risk Factors, and Markers of Inflammation
Heriberto Rodriguez-Hernandez et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2013)
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Naga Chalasani et al.
HEPATOLOGY (2012)
C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients
Esther Zimmermann et al.
JOURNAL OF HEPATOLOGY (2011)
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Bolormaa Vandanmagsar et al.
NATURE MEDICINE (2011)
C-C Chemokine Receptor 2 (CCR2) Regulates the Hepatic Recruitment of Myeloid Cells That Promote Obesity-Induced Hepatic Steatosis
Amrom E. Obstfeld et al.
DIABETES (2010)
High-sensitivity C-reactive protein as a serum predictor of nonalcoholic fatty liver disease based on the Akaike Information Criterion scoring system in the general Japanese population
Tomomi Kogiso et al.
JOURNAL OF GASTROENTEROLOGY (2009)
High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH
Masato Yoneda et al.
JOURNAL OF GASTROENTEROLOGY (2007)
C-reactive protein and its role in metabolic syndrome: mendelian randomisation study
NJ Timpson et al.
LANCET (2005)
Association between C-reactive protein and features of the metabolic syndrome -: A population-based study
M Fröhlich et al.
DIABETES CARE (2000)
分享论文
